BeVITAL Launched in U.S

Vital Connect Inc., a designer of wearable biosensor technologies and BePATIENT, a startup developing patient-centric digital health solutions, have deployed “BeVITAL” in North America.

The remote patient monitoring solution combines Vita Connect’s FDA cleared biosensor called “HealthPatch® MD” with BePATIENT’s web-based solution and app which allows personalized healthcare programs to be accessible through mobile devices and computers.

The technology is able to monitor and transmit eight FDA and CE cleared biometric data streams from HealthPatch MD directly to the practitioners’ smart phones, tablets, or computers. In addition, BeVITAL, can provide individualized care plans to patients plus meaningful insights to clinicians and researchers.

This spring, BeVITAL will be used in a post discharge heart failure patient monitoring study at John Muir Medical Center in Walnut Creek and Concord California. Dr. Neal White, Heart Failure Director at John Muir said, “We’re looking forward to seeing how sensor technology and connected patients can help to improve heart failure outcomes that includes reducing readmission.”

The technology will also be used to follow patients returning home after outpatient surgical procedures at Hospital Infantile De Las Californias in Tijuana, in a study undertaken by Scripps Translational Science Institute in San Diego.

BeVITAL has already made it possible to monitor the post discharge of over 80 surgical patients in clinical studies at five hospitals in Europe with two more hospitals to be scheduled this summer.


Share Button